Unparalleled research contrast agent
BriteVu, Scarlet Imaging’s first product, is an unparalleled research contrast agent. BriteVu is easy to use, has high radiodensity and penetrates to the capillary level. Using radiographs or CT, researchers can study a subject’s vascular system with incredible detail. BriteVu can also be used to study the respiratory system, body cavities and other non-vascular systems of conceivably any animal. Additionally, BriteVu can be used to perfuse small spaces (1-5 µm) of mechanical and other non-animal structures for non-destructive CT analysis.
BriteVu advantages
Comparison of Commercially Available Terminal Vascular Contrast Agents
BriteVu was developed out of necessity. To achieve the research results I needed for my work, I had to invent BriteVu. In the process of testing currently available products, I realized that terminal contrast agents were highly toxic (to the researchers and environment), did not achieve the results needed (high contrast down to the capillary level), had short working times and were expensive. Additionally, researchers could not easily converse with existing companies. BriteVu was developed and Scarlet Imaging formed to address all these issues. Plus, when clients reach out to us at Scarlet Imaging, we respond in a timely manner to help solve their problems.
M. Scott Echols, DVM, Dipl ABVP
President
Scarlet Imaging, LLC
Inexpensive
Competing products are far more expensive
Superior results
Penetrates capillaries with high radiodensity
Versatility
Can be used with radiographs, MRI and CT, as well as in multiple animal species
Easy to use
Highly stable, safe and easy to administer